Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Andy Kiser

Surgery Pittsburgh, PA Medical Doctor

NPI 1396759460 CMS profile 659108

1050 Bower Hill Rd Ste 204, Pittsburgh, PA 15243

Open in the dashboard

General payments

$1,009,564

506 records reported · program years 2019–2025

Research payments

$800

Paid to them · 1 record reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Research they led as principal investigator

$106,068 paid to institutions, not to them · program years 2019–2022

Through program year 2025, Andy Kiser of Pittsburgh, PA is reported in the CMS Open Payments database as having received $1,009,564 across 506 general payments and $800 in research payments paid to them. Separately, studies naming them as principal investigator received $106,068 in research payments, paid to institutions rather than to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them. The principal-investigator line is research money paid to institutions for studies they led — not to them — and is not added to anything either.

General payments for this record sit in the 99th percentile of Surgery profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

8 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $134,322 87
2024 General $29,730 74
2023 General $93,780 114
2022 General $285,604 92
2021 General $238,721 73
2020 General $69,889 23
2019 General $157,519 43
2019 Research $800 1

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Andy Kiser
  • Surgery median
  • Middle half of Surgery
  • National median

In program year 2025, general payments to Andy Kiser were reported at $134,322. Among 17,702 Surgery profiles paid that year, the median was $280 and the middle half received between $91 and $1,259.

Show as a table
Year Andy Kiser Surgery median Middle half National median
2019 $157,519 $253 $82–$1,521 $163
2020 $69,889 $131 $40–$706 $114
2021 $238,721 $168 $50–$904 $132
2022 $285,604 $224 $76–$1,218 $149
2023 $93,780 $253 $82–$1,255 $160
2024 $29,730 $279 $90–$1,381 $164
2025 $134,322 $280 $91–$1,259 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Atricure, Inc. $418,446 79 payments
  2. AngioDynamics, Inc. $223,763 7 payments
  3. Edwards Lifesciences Corporation $162,565 152 payments
  4. Medtronic, Inc. $115,292 126 payments
  5. Abbott Laboratories $76,677 74 payments
  6. Spiration, Inc. $6,677 7 payments
  7. Philips Electronics North America Corporation $3,874 2 payments
  8. Medtronic Vascular, Inc. $566 6 payments
  9. Maquet Cardiovascular U.S. Sales, L.L.C. $213 6 payments
  10. Abiomed $194 2 payments
  11. Other $1,297 45 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Consulting Fee $499,478 142 payments
  2. Grant $350,750 6 payments
  3. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $112,663 9 payments
  4. Travel and Lodging $29,102 93 payments
  5. Food and Beverage $15,087 254 payments
  6. Education $2,486 2 payments
Products named General payments · program years 2019–2025
  1. SYNERGY ABLATION SYSTEM $396,352 49 payments
  2. Avalus $111,519 54 payments
  3. EDWARDS SAPIEN 3 TRANSCATHETER HEART VALVE (THV) $16,778 14 payments
  4. AngioVac $16,725 1 payment
  5. VANTAGEVIEW $14,963 13 payments
  6. ATRICLIP LAA EXCLUSION SYSTEM $13,844 15 payments
  7. TENDYNE $9,625 8 payments
  8. EPI-SENSE GUIDED COAGULATION SYSTEM WITH VISITRAX $9,456 6 payments
  9. NAVITOR $8,680 7 payments
  10. AtriCure cryoICE cryoSPHERE Cryoablation System $7,675 7 payments
  11. Other $28,046 185 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Research payments came from Research payments · program years 2019–2025
  1. Abbott Laboratories $800 1 payment

Prescribing to Medicare patients

Part D · data year 2024 · 1 drug

Part D claims

13

Median for Thoracic Surgery: 42

Drug cost

$48

Median for Thoracic Surgery: $318

Branded share of claims

0%

Median for Thoracic Surgery: 0%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Furosemide Generic 13 $48

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 910 Part D prescribers listed as Thoracic Surgery; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 47 billing codes

Paid by Medicare

$54,772

Medicare's payments for the services billed

Medicare patients

74

Average age 78

Services billed

217

19 women, 55 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Heart failure 64%
Ischemic heart disease 59%
Diabetes 49%
Chronic kidney disease 47%
Atrial fibrillation 46%
Arthritis 46%
Cancer 23%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

507 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Surgery in Pennsylvania

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record